BioD
BioD, LLC is a privately held, vertically integrated biotechnology company headquartered in Cordova, United States. Founded in 2005, the firm operates with 11-50 employees, though specific therapeutic focus, products, and technology platforms are not detailed in available sources.
- Company typePrivate
- Founded2005
- HeadquartersCordova, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What BioD does
BioD, LLC is a privately held biotechnology company founded in 2005 and headquartered in Cordova, Tennessee, United States. The firm describes itself as vertically integrated, which implies it operates across multiple stages of the biotechnology value chain internally rather than outsourcing core functions, though the specific therapeutic areas, modalities, or product portfolio are not detailed in the available source materials. The company maintains a headcount of 11-50 employees, a size band consistent with a small-cap specialty biotech rather than a fully scaled commercial operation, and operates a website at biodlogics.com that signals a likely biologics orientation.
The available input data contains no details on BioD's product portfolio, technology platforms, patents and trademarks, regulatory certifications, distribution channels, marketing channels, pricing, customers, management team, funding history, recent strategic actions, or geographic footprint. As a privately held company with no public ticker and no documented funding rounds, BioD's revenue model, go-to-market mechanics, capital structure, and commercial status cannot be characterized from these sources. Investors evaluating the firm would require direct management dialogue, FDA/regulatory filings where applicable, or proprietary data sources to confirm its therapeutic focus, technology stack, IP position, and competitive standing.
The only market-context reference in the source material is a USD 32.44 billion 2025 global bar soap market figure (projected to USD 48.14 billion by 2034), which the source itself flags as only potentially relevant if BioD operates in natural or eco-friendly personal care — a positioning inconsistent with the firm's stated biotechnology identity. This market reference should be treated as low-relevance context rather than a directly applicable sizing for BioD's addressable market.
BioD firmographics
Firmographics- Name
- BioD
- Website
- https://biodlogics.com
- Company type
- Private
- Founded year
- 2005
- Headcount range
- 11–50 employees
- Short description
- BioD, LLC is a privately held, vertically integrated biotechnology company headquartered in Cordova, United States. Founded in 2005, the firm operates with 11-50 employees, though specific therapeutic focus, products, and technology platforms are not detailed in available sources.
- Ownership category
- akta.pro rank
BioD industry classification
Industry- Product category
- Biologics Manufacturing
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Biologics (mAbs/Recombinant Proteins) CDMO (HLAGABAC)
Keywords
Where BioD is headquartered
LocationHeadquarters
- HQ city
- Cordova
- HQ country
- United States
- HQ region
- North America
Markets served
BioD business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
BioD product offering
Product offeringCore offering
BioD, LLC is a vertically integrated biotechnology company. The firm operates across the full value chain of biologic product development, manufacturing, and commercialization, though specific product offerings, therapeutic areas, and customer segments are not detailed in the available source material.
Differentiator
Problem solved
Functional benefit
Companies that use BioD
Customer profileIdeal customer profiles1 record
BioD technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
BioD partnerships and signals
Strategic signalScale indicators1 record
BioD competitors and assessment
Company assessmentEmerging players
- CollPlant Biotechnologies: CollPlant develops recombinant human collagen-based regenerative products for orthopedics and wound care, an emerging tissue-biologics competitor that targets similar clinical use cases to BioD's allografts.
- Vericel: Vericel commercializes advanced cell therapies and biologic products for severe burn and cartilage repair, representing an adjacent tissue/biologic competitor serving overlapping surgical and wound care end markets.
Direct peers
- Osiris Therapeutics (a Smith & Nephew company): Osiris developed placental and adipose tissue allografts (Grafix, OvationOS) for wound healing and orthopedic applications, making it a near-direct comparand to BioD's amniotic tissue platform.
- Anika Therapeutics: Anika Therapeutics is a regenerative medicine and orthobiologics company (hyaluronic acid-based HA, surgical tissue products) competing with BioD in the surgical reconstruction and sports medicine adjacencies.
- Organogenesis: Organogenesis is a regenerative medicine company commercializing wound care and surgical biologics (Apligraf, Dermagraft, PuraPly), competing head-to-head with BioD in tissue-based advanced wound care and surgical reconstruction.
- MiMedx: MiMedx develops and markets placental tissue allografts (EpiFix, AmnioFix) for wound care and surgical applications, the closest direct competitor to BioD's amniotic membrane-based product line.
- AlloSource: AlloSource is a nonprofit tissue manufacturer providing allografts for wound care, sports medicine, and surgical reconstruction, competing directly with BioD across amniotic and connective tissue allograft categories.
Broad incumbents
- Smith & Nephew: Smith & Nephew offers a broad advanced wound management and orthobiologics portfolio (including skin substitutes and tissue regeneration products) that overlaps with BioD's clinical use cases.
- Stryker: Stryker is a diversified medtech incumbent with orthobiologics, regenerative, and surgical reconstruction product lines that compete broadly with BioD across hospital and ambulatory surgical channels.
- Integra LifeSciences: Integra LifeSciences is a global surgical reconstruction and neurosurgery medtech leader whose product catalog now features BioD's amniotic tissue technology, making it both a commercial partner and a broad incumbent comparator.
Market position
Strengths2 records
Weaknesses4 records
Key risks4 records
Key highlights4 records
Customer concentration
BioD social profiles
Digital presenceBioD financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioD leadership team
Management profileNumber of profiles
BioD funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioD M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioD
What does BioD do?
BioD, LLC is a vertically integrated biotechnology company. The firm operates across the full value chain of biologic product development, manufacturing, and commercialization, though specific product offerings, therapeutic areas, and customer segments are not detailed in the available source material.
When was BioD founded?
BioD was founded in 2005. It employs 11 to 50 people.
Where is BioD based?
BioD is headquartered in Cordova, United States, in the North America region.
Who are BioD's main competitors?
Emerging players on record are CollPlant Biotechnologies and Vericel. Direct peers are Osiris Therapeutics (a Smith & Nephew company), Anika Therapeutics, Organogenesis, MiMedx and AlloSource. Broad incumbents are Smith & Nephew, Stryker and Integra LifeSciences.
Does BioD have an API?
No public API is recorded for BioD.
What industry is BioD in?
BioD's product category is Biologics Manufacturing. Its primary akta.pro industry code is HLAGABAC, Biologics (mAbs/Recombinant Proteins) CDMO. Its NAICS code is 325414 and its SIC code is 2836.